Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc. REGN34

Market Closed
22 Nov, 19:55
B3 B3
R$
71. 54
-0.98
-1.35%
R$
98.44B Market Cap
24.52 P/E Ratio
0% Div Yield
526 Volume
42.79 Eps
R$ 72.52
Previous Close
Day Range
71.51 72.52
Year Range
64.4 111.72
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
31 Jan 2025 (69 Days)
11.38
Cons. EPS
-
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
31 Oct 2024
11.69
Cons. EPS
12.46
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
1 Aug 2024
10.61
Cons. EPS
11.56
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
2 May 2024
10.09
Cons. EPS
9.55
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
2 Feb 2024
10.73
Cons. EPS
11.86
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
2 Nov 2023
10.72
Cons. EPS
11.59
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
4 Nov 2016
2.71
Cons. EPS
3.13
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
4 Aug 2016
2.65
Cons. EPS
2.82
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
5 May 2016
2.58
Cons. EPS
2.57
EPS
Regeneron Pharmaceuticals Inc logo
REGN Regeneron Pharmaceuticals Inc
9 Feb 2016
3.36
Cons. EPS
2.83
EPS